World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 3 October 2016
Main ID:  NCT02360540
Date of registration: 05/02/2015
Prospective Registration: Yes
Primary sponsor: University Hospital, Angers
Public title: PERCEPIC: PERC Rule Combined With Implicit Low Clinical Probability PERCEPIC
Scientific title: Performance of the Pulmonary Embolism Rule-out Criteria (the PERC Rule) Combined With Implicit Low Clinical Probability (Gestalt) to Rule-out PE Without Further Exams
Date of first enrolment: May 2015
Target sample size: 1773
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02360540
Study type:  Observational [Patient Registry]
Study design:  Observational Model: Cohort, Time Perspective: Prospective  
Phase:  N/A
Countries of recruitment
Belgium France
Contacts
Name:     Andréa PENALOZA, MD-PhD
Address: 
Telephone:
Email:
Affiliation:  Clinique Universitaire Saint-Luc, Bruxelles
Name:     Pierre-Marie ROY, MD-PhD
Address: 
Telephone:
Email:
Affiliation:  UH Angers
Key inclusion & exclusion criteria

Inclusion Criteria:

- Patients admitted to the emergency department for one of the following criteria :

- Dyspnea and/or Thoracic pain without another obvious cause

- Pulmonary embolism suspicion whatever the reason

Exclusion Criteria:

- Age lower than 18

- Patients hospitalized for more than 48h

- Ongoing curative anticoagulant therapy for more than 48h before admission

- Patients with thromboembolic disease diagnosed before the admission

- Unavailability for follow-up (short life expectancy, no phone number…)

- Patient refusing to be contacted by phone at 3 month

- Patient refusing that medical data were collected

- Secondary exclusion criteria : curative anticoagulant therapy for more than 5 days
during the 3 month follow-up for another reason than thromboembolic disease.



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Pulmonary Embolism
Thoracic Pain
Dyspnea
Intervention(s)
Other: Gestalt estimation
Primary Outcome(s)
To assess the accuracy of the combination of low implicit clinical probability (gestalt) and negative PERC rule (8 criteria absents) [Time Frame: 3 months]
Secondary Outcome(s)
To assess the accuracy of PERC and low clinical probability combination depending of clinical probability assessment method (implicit assessment, revised Geneva Score, Wells Score and implicit overridden Geneva Score) [Time Frame: 3 months]
To assess usefulness of PERC and implicit low clinical probability combination to reduce the use of further exams [Time Frame: During emergency managment]
To compare performances of clinical probability assessment methods : implicit assessment, revised Geneva Score, Wells Score and implicit overridden Geneva Score [Time Frame: 3 months]
Secondary ID(s)
PHRC2014_02
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history